Name | 1-[(3S,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3-(methoxymethyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-imidazol-1-ylethanone |
---|---|
Synonyms |
UNII-1GA9JVO9ZA
Pregnan-20-one,3-hydroxy-21-(1H-imidazol-1-yl)-3-(methoxymethyl)-,(3alpha,5alpha) |
Description | Posovolone (Co 134444) is an orally active sedative-hypnotic neuroactive steroid. Posovolone has anticonvulsant and anxiolytic-like activity as well as ataxic effects[1]. |
---|---|
Related Catalog | |
In Vitro | In mice, Co 134444 (0.5-10 mg/kg, IP, 15 min; 1-60 mg/kg, PO; 30 min) demonstrates efficacy against pentylenetetrazol (PTZ)-induced seizures with an ED50 of 3.3 mg/kg after IP administration and 9.8 mg/kg orally. Similarly, protection against maximal electroshock (MES) is observed with an ED50 of 4.8 mg/kg IP and 20.6 mg/kg PO. In rats, Co134444 (10-40 mg/kg; PO; 30 min) protects against PTZ-induced seizures and MES-induced seizures with an ED50 of 23.6 mg/kg and 25.3 mg/kg, respectively[1]. |
References |
Molecular Formula | C26H40N2O3 |
---|---|
Molecular Weight | 428.60700 |
Exact Mass | 428.30400 |
PSA | 64.35000 |
LogP | 4.48860 |